d-alpha tocopherol has been researched along with dutasteride in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bartsch, G; Boccon Gibod, L; Djavan, B; Iversen, P; Marberger, M; Schulman, C; Teillac, P; Zlotta, A | 1 |
| Hakenberg, OW; Wirth, MP | 1 |
| Frazee, LA; Lowe, JF | 1 |
| Gescher, AJ; Jain, S; Marczylo, TH; Mellon, JK; Steward, WP; Thorpe, JF | 1 |
| Sarvis, JA; Thompson, IM | 1 |
| Fitzpatrick, JM; Schröder, FH; Schulman, C; Zlotta, AR | 1 |
| Nambiar, D; Singh, RP | 1 |
| Andriole, GL; Freedland, SJ; Hamilton, RJ; Vemana, G | 1 |
9 review(s) available for d-alpha tocopherol and dutasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemotherapeutic prevention studies of prostate cancer.
Topics: Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Prostatic Neoplasms; Vitamin E | 2004 |
[Prevention of prostate cancer].
Topics: 5-alpha Reductase Inhibitors; Animals; Anticarcinogenic Agents; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Fishes; Flavonoids; Fruit; Humans; Isoflavones; Lycopene; Male; Neoplasms, Hormone-Dependent; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Soy Milk; Tea; Vegetables; Vitamin D; Vitamin E | 2005 |
Update on prostate cancer chemoprevention.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins | 2006 |
A review of phase III clinical trials of prostate cancer chemoprevention.
Topics: Antineoplastic Agents; Azasteroids; Clinical Trials, Phase III as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Prostatic Neoplasms; Selenium Compounds; Vitamin E | 2007 |
Androgens and prevention of prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Azasteroids; Dutasteride; Finasteride; Humans; Male; Prostate; Prostatic Neoplasms; Selenium; Signal Transduction; Vitamin E | 2008 |
Prostate cancer: a serious disease suitable for prevention.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Toremifene; Vitamin E | 2009 |
Advances in prostate cancer chemoprevention: a translational perspective.
Topics: Androgen Antagonists; Animals; Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Curcumin; Disease Models, Animal; Dutasteride; Finasteride; Flavonoids; Genistein; Humans; Lycopene; Male; Phytochemicals; Polyphenols; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Silybin; Silymarin; Tea; Vitamin E | 2013 |
Chemoprevention of prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Dietary Supplements; Dutasteride; Finasteride; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Lycopene; Male; Plant Extracts; Primary Prevention; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Serenoa; Vitamin E | 2014 |